Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Riddell

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Human Gene Therapy|June 1, 1992
Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of OncologyS R Riddell, P D Greenberg, R W Overell, et al.
Nature Medicine|February 1, 1996
T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patientsS R Riddell, M Elliott, D A Lewinsohn, et al.
The Journal of Experimental Medicine|January 10, 2001
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processingA G Brickner, E H Warren, J A Caldwell, et al.
The Cancer Journal From Scientific American|June 10, 1998
Genetic modification of T-cell clones for therapy of human viral and malignant diseasesP D Greenberg, R J Finch, M A Gavin, et al.
Tissue Antigens|May 10, 2012
HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotypeT Yamamura, J Hikita, M Bleakley, et al.
The Journal of Infectious Diseases|December 23, 1999
High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfectionsX Jin, M A Demoitie, S M Donahoe, et al.
Nature Communications|September 27, 2024
Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansionS Fiorenza, Y Zheng, J Purushe, et al.
Human Gene Therapy|August 20, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 28, 1999
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 1, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Human Gene Therapy|June 1, 1992
Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of OncologyS R Riddell, P D Greenberg, R W Overell, et al.
Nature Medicine|February 1, 1996
T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patientsS R Riddell, M Elliott, D A Lewinsohn, et al.
The Journal of Experimental Medicine|January 10, 2001
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processingA G Brickner, E H Warren, J A Caldwell, et al.
The Cancer Journal From Scientific American|June 10, 1998
Genetic modification of T-cell clones for therapy of human viral and malignant diseasesP D Greenberg, R J Finch, M A Gavin, et al.
Tissue Antigens|May 10, 2012
HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotypeT Yamamura, J Hikita, M Bleakley, et al.
The Journal of Infectious Diseases|December 23, 1999
High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfectionsX Jin, M A Demoitie, S M Donahoe, et al.
Nature Communications|September 27, 2024
Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansionS Fiorenza, Y Zheng, J Purushe, et al.
Human Gene Therapy|August 20, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 28, 1999
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 1, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Pageof 8